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Background: Plantar fasciitis is a common condition routinely managed by podiatrists in the 
community and is widely treated conservatively. Two commonly used treatments for plantar 
fasciitis are customized functional foot orthoses and corticosteroid injections. While common 
to clinical practice, the evidence base underpinning these treatment strategies is unknown. 
  Therefore, the aim of this systematic review was to assess the effectiveness and safety of custom-
ized functional foot orthoses and corticosteroid injections in the treatment of plantar fasciitis.
Methods: A systematic literature search was conducted. Experimental studies, in English, 
from 1998 to 2010 were accepted for inclusion in this review. The PEDro quality assessment 
tool and the National Health and Medical Research Council’s hierarchy of evidence were used 
to assess the quality of the included studies.
Results: Six randomized controlled trials which met the selection criteria were included in this 
review. Four reported on customized functional foot orthoses and 2 on corticosteroid   injections. 
Current best available evidence highlights that both customized functional foot orthoses 
and corticosteroid injections can lead to a decrease in pain associated with plantar fasciitis. 
  Additionally, customized functional foot orthoses may also provide an additional benefit in 
terms of increased functional ability in patients with plantar fasciitis. Corticosteroid injections 
may have side effects, especially pain (from the injection).
Conclusion: Both customized functional foot orthoses and corticosteroid injections can 
lead to reduction in pain associated with plantar fasciitis. While customized functional foot 
orthoses may increase the functional outcomes in patients with plantar fasciitis, corticosteroid 
injections may have side effects (especially pain as a result of the injection), which may limit 
its acceptability.
Keywords: plantar fasciitis, heel pain, orthotics, orthoses, cortisone injection, corticosteroid 
injection
Introduction
Evidence-based practice (EBP) is now a firmly entrenched philosophy for providing 
both safe and quality health care. Evidence based practice is defined as “the con-
scientious, explicit and judicious use of current best evidence in making decisions 
about the care of individual patients”1 and is underpinned by 3 equally important 
concepts, namely, best research evidence, clinical expertise and patient values.1 
While the importance of EBP is universally recognized, EBP in podiatry is still in 
its infancy. Podiatry’s foray into EBP is shrouded by a lack of rigorous high quality 
evidence, limited research capability and/or opportunities for podiatrists, and barri-
ers in accessing and implementing evidence into clinical practice.2,3 However, with 
increasing emphasis on EBP in health care, podiatrists too are required to ensure Journal of Multidisciplinary Healthcare 2011:4 submit your manuscript | www.dovepress.com
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their practices are underpinned by current best research 
evidence.
Plantar fasciitis is a common condition routinely 
managed by many podiatrists in the community, as they 
are primary contact practitioners. Therefore, it is essential 
that podiatry management strategies for plantar fasciitis 
are underpinned by EBP principles to ensure that optimal 
outcomes are attained. Although most commonly described 
as an inflammatory condition (plantar fasci’itis), researchers 
have questioned the presence of inflammation in this 
condition.4,5 Plantar fasciitis is reported to commonly occur 
in runners and those who are overweight.6–9 Furthermore, 
research indicates that 10% of the general population 
will also experience this pathology at least once in their 
lifetime.6,7,10 The most commonly reported symptom of 
plantar fasciitis is described as “first-step pain”, though 
plantar heel pain in general can be broadly associated with 
plantar fasciitis within the literature.6,9,11
The plantar fascia, also known as the plantar aponeurosis 
is a broad, flat, fibrous, tendon-like structure, which consists 
of noncontractile irregularly ordered collagen fibers with 
minimal elastic properties.12,13 It originates from behind the 
medial tubercle of the calcaneus and then divides distally 
in the area of the metatarsal heads into both its superficial 
and deep segments. The superficial fibers insert into the 
skin, whilst the deep segments attach to the transverse 
metatarsophalangeal ligaments and to the plantar surface of 
the proximal digits.13 The plantar fascia provides stability 
to the arch of the foot and aids in re-supination of the foot 
during propulsion.14,15
Conservative treatments remain popular for many patients 
with plantar fasciitis. A recent clinical practice guideline, 
recommends a number of conservative interventions in the 
management of plantar fasciitis.16 Among these conserva-
tive treatment options prefabricated foot orthoses (PFO), 
customized functional foot orthoses (CFO) and corticosteroid 
injections feature regularly (CSI).7–11,16–22
Clinicians may be led to the use of PFO and CFO for 
the treatment of plantar fasciitis, in the belief that these 
provide a mechanical correction to the poor and/or altered 
biomechanics of the symptomatic foot, ultimately relieving 
the symptoms associated with plantar fasciitis.6 This treat-
ment may be seen as having clinical benefit, as the clinician 
is trying to address the etiology of the condition, rather than 
simply “masking” the symptoms. Conversely, clinicians may 
look to use CSI as their treatment of choice as they are often 
considered a “quick fix”, are relatively easy to administer, 
and time and resource efficient.
These conservative treatments are routinely used in 
  clinical practice, and widely recommended, yet there is no 
evidence based consensus on the most effective treatment for 
plantar fasciitis. Emerging evidence suggests that both CSI 
and PFO should be considered as part of the “tier 1 treat-
ment options”, whilst CFO should be considered as part of 
the “tier 2 treatment options”. However, the evidence base 
underpinning these recommendations could be considered to 
be low level and low quality.23 Despite this limited evidence 
base, in clinical practice, CFO and CSI remain popular, 
possibly driven by patient expectations and fee for service 
model. Confounding these issues are the known side effects, 
discomfort, and injection pain respectively for the use of 
CFO and CSI.4,5,23–26
Preliminary scoping search of the literature identified no 
study directly comparing CFO to CSI for the treatment of 
plantar fasciitis. In the absence of direct comparison between 
the two, literature which contained either of these as treat-
ment options (with alternate comparators) was considered. 
Therefore, the primary aim of this systematic review was to 
assess the effectiveness of CFO and CSI in the management 
of plantar fasciitis. The secondary aim of this review was to 
report on the safety and, in particular, the side effects, associ-
ated with the use of these two interventions.
Methods
Data sources
Electronic databases were searched (Ovid [Medline], 
EMBASE, AMED, PubMed, SportDiscus, CINAHL, 
Cochrane Library, and AUSPORT) up to December 2010. 
The following search term combinations were used:
1.  orthotic* or orthoses or functional foot orthotic* or func-
tional foot orthoses or insert* or insole* AND plantar 
fasciitis or anterior medial heel pain or plantar heel pain 
or heel spur syndrome or painful heel syndrome or plantar 
aponeurosis
2.  cortisone inject* or corticosteroid* inject* or steroid 
shot* or steroid injection AND plantar fasciitis or anterior 
medial heel pain or plantar heel pain or heel spur syn-
drome or painful heel syndrome or plantar aponeurosis.
(*Indicates truncation)
Study selection
Only properly designed randomized control trials (RCT), 
which are considered to be level II in the hierarchy of 
evidence (National Health and Medical Research Coun-
cil’s [NHMRC] designation of levels of evidence), from 
the past decade, published as peer review journal articles Journal of Multidisciplinary Healthcare 2011:4 submit your manuscript | www.dovepress.com
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were accepted for inclusion in this review. In the interests 
of accessing best evidence for this review, only the high-
est level of RCT (level II) were sought after for inclusion 
into this review. For the study to be considered a properly 
designed randomized control trial, the method of randomiza-
tion needed to be both rigorous and adequately described. 
Alternate allocation and other means, such as date of birth 
and sequential, are not considered rigorous techniques of 
randomization. With rigorous randomization process, there is 
equal probability of participants being allocated to each and 
every treatment group.27 Inadequate randomization can lead 
to incorrect higher estimation of treatment effects, resulting 
in introduction of bias in the methodology.27 For this reason, 
inadequate randomization techniques, and studies without 
adequate descriptions of randomization methods, were not 
considered for inclusion into this review. The other limiters 
include English language publications and research in human 
subjects only.
Only subjects with a diagnosis of plantar fasciitis were 
included as the population group. Custom made functional 
foot orthoses needed to be a pair of in-shoe devices that were 
moulded or milled from impressions of the feet, whether by 
plaster cast or 3D laser scan. The fabrication then needed to be 
carried out according to practitioner-prescribed   specifications.28 
The CSI treatment had to involve an injection of a corticoster-
oid solution into the area of the plantar fascia.
Types of comparators included were, but not limited 
to: Achilles’ tendon and plantar fascia stretching programs, 
extracorporeal shock wave therapy, manipulations of the 
foot and ankle, prefabricated foot orthoses, night splints (calf 
and/or plantar fascia), true “sham” foot orthotic devices and 
autologous blood injections.
Pain and function were chosen as the outcome measures 
of interest as these measures are routinely collected and 
reported in clinical practice.
Authors HU and EB reviewed all potential search “hits” 
following the results of the above literature search. The 
full text, the abstract, or the design methodology was used 
to ascertain the relevance of the article to this review. Any 
potential articles were set aside for further scrutiny and then 
from these, the final articles were selected.
Methodological quality assessment
The authors collaboratively assigned the chosen articles to the 
appropriate level of hierarchy with the NHMRC designation 
of level of evidence categories.29 PEDro quality assessment 
tool was applied to the included articles by both HU and EB 
independently. Any discrepancies in the assigned marks 
were addressed during discussions between HU and EB until 
agreement was found. The PEDro assessment tool contains 
11 domains (10 included in the final score) which appraise 
the methodological rigor of randomized control trials and 
clinical control trials.30
Data extraction
The data were extracted independently by HU and EB using 
the same data extraction table. The data tables were then 
compared and any difference in the data collection was 
further scrutinized until resolution was found. Demographic 
data were collected pertaining to the subjects within the 
selected studies, as were the outcome measures utilized and 
the results of the within-group changes for each treatment 
arm of interest. Data relevant to the information utilized by 
the PEDro instrument were also collected.30
Results
Search results
Six properly designed RCTs (level II evidence) were 
retained for this systematic review.6,9,20,23,31,32 Seven pseudo-
randomized trials were identified from the literature but 
due to an inadequate randomization process or the absence 
of randomization description, were excluded from this 
review.8,11,17,19,33–35 A summation of both the included and 
excluded studies can be found in Table 1. Figure 1 provides 
an overview of the literature selection process.
Four studies investigated the effectiveness of CFO.6,9,20,32 
The study by Roos and colleagues6 randomized a total of 
43 subjects into a CFO group (n = 10 at final), a night splint 
group (n = 15 at final) or a combined night splint and CFO 
group (n = 13 at final). Assessment measurements of pain and 
function were measured at baseline; 6, 12, 26, and 52 weeks. 
Landorf and colleagues9 recruited a total of 136 participants 
initially and randomized them into 1 of 3 groups; a sham 
orthotic group (n = 43 at final), a prefabricated orthotic 
group (n = 43 at final), or a CFO group (n = 45 at final). 
The outcomes of pain and function were measured at 3 and 
12 months post intervention. The study by Dimou and col-
leagues20 randomly allocated 20 subjects into either group: 
1 which received chiropractic adjustments of the foot and 
ankle twice a week for 4 weeks (n = 10) or group 2 which 
received a pair of CFO to wear for 8 weeks (n = 10). The 
outcome of pain was measured subjectively and objectively, 
using an Algometer, at baseline, day 15, day 29, and then at 
1 month. Baldassin and colleagues32 initially randomized 142 
participants to either a prefabricated orthoses group (n = 72) 
or a CFO group (n = 70). The outcome of pain was measured Journal of Multidisciplinary Healthcare 2011:4 submit your manuscript | www.dovepress.com
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at baseline, 4 weeks, and 8 weeks. The primary pain outcome 
was a modified subscale of the Foot Function Index (FFI), 
whilst the secondary pain outcome was pain elicited by palpa-
tion of the medial calcaneal tuberosity. Data were complete 
at final analysis for 54 participants in the prefabricated group 
and 51 participants in the CFO group. No “intention to treat” 
approach was applied to statistical analysis.
The remaining 2 studies evaluated the effectiveness 
of CSI.23,31 Porter and Shadbolt23 recruited a total of 125 
patients and randomized them into group A (n = 64 heels), 
which received 1 injection of a corticosteroid and group 
B (n = 61 heels) which received electro hydraulic shock 
wave therapy (ESWT). Both groups performed a standard 
  stretching program for gastrocnemius, soleus, and plantar 
fascia. A third group C consisted of 19 “heels” that were 
eligible for the study but refused either a CSI or ESWT treat-
ment and therefore only performed the stretching exercises. 
All patients were assessed for pain measures at baseline, 
3 months, and 12 months. Lee and Ahmad31 randomized 
64 participants into an autologous blood intralesional injec-
tion (n = 30) or CSI treatment group (n = 31). The outcome 
measure of pain was taken at baseline, 6 weeks, 3 months, 
and 6 months post treatment.
An overview of the psychometric properties for the 
outcome measures reported in the included studies is sum-
marized in Table 2. A range of different outcome measures, 
including subjective and objective measures were reported. 
Subjective measures often related to pain severity and 
intensity (such as the Visual Analog Scale, Numeric Pain 
Rating Scale, and First Step Pain Scale) and also included 
measures of the impact of pain on function (Foot Health 
Status Questionnaire). Objective measures were primarily 
related to palpation findings (such as Tenderness Threshold). 
While psychometric properties of most of these outcome 
measures were recognized and reported, one study by Dimou 
and colleagues20 did not justify the psychometric properties 
of the First Step Pain Scale and the “Effect of Heel Pain on 
3 Different Activities” form.
Roos et al6 reported no significant difference in pain 
scores (at any measurement points) between the 3 groups. 
When comparing the CFOs and the splint-only group, a 
clinically important difference in sport and recreation was 
observed at 26 weeks (assumed to be an increase in participa-
tion, but not stated). In addition, at 52 weeks the groups that 
were treated with CFOs reported a significantly higher pain 
reduction when compared with the splint alone group.
Landorf et al9 also reported a reduction in pain between 
study groups, but not a statistically significant reduction. 
Prefabricated foot orthoses and CFO were shown to cause 
a statistically significant improvement in function when 
compared with sham orthoses in the short term (3 months) 
but not in the long term (12 months). Dimou et al20 reported 
a significant difference for pain between the chiropractic 
treatment group and the CFO treatment group, with the 
chiropractic group being superior.
Baldassin and colleagues32 when comparing the effective-
ness of low-cost prefabricated and customized foot orthoses, 
reported that both groups had similar outcomes. The findings 
from this study indicate that while there was a significant 
improvement in outcomes (both in pain and function) when 
Table 1 included and excluded randomized controlled trials
Article Randomization  
technique
Included/ 
excluded
Lee and Ahmad31 Computer generated included
Roos et al6 Randomly ordered envelopes  
within a box
included
Landorf et al9 Computer generated included
Porter and  
Shadbolt23
envelopes included
Dimou et al20 Selection of a slip of randomly  
collated paper labeled either  
group 1 or group 2
included
Baldassin et al32 Opaque sealed envelopes included
Lynch et al8 NR excluded
Martin et al11 NR excluded
Pfeffer et al17 NR excluded
Turlik et al19 NR excluded
Kalaci et al33 Consecutive allocation excluded
Mulherin and  
Price34
Consecutive allocation excluded
Yucel et al35 NR excluded
Abbreviation: NR, not reported.
267 “Hits” from running
above search
32 potential inclusions set
aside for closer scrutiny
235 articles excluded 
13 potential RCTs assessed
against eligibility criteria 
7 RCTs excluded for not meeting
the description of a properly 
designed RCT 
6 articles retained for
systematic review
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Figure 1 Literature selection process.
Abbreviation: RCT, randomized controlled trial.Journal of Multidisciplinary Healthcare 2011:4 submit your manuscript | www.dovepress.com
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compared with baseline, there were no differences between 
the groups at 4 and 8 weeks post intervention. These findings 
indicate that low-cost prefabricated orthoses are at least as 
effective in reducing pain and improving function as custom-
ized orthotic devices.
The 2 studies which investigated the use of CSI dem-
onstrated statistically significant reductions in pain with 
between group comparisons.23,31 However, Porter and Shad-
bolt reported that at 12 months the CSI and ESWT group 
had similar levels of average pain while the control group 
had significantly higher levels of pain.23 Similarly, Lee and 
Ahmad’s study reported the corticosteroid group to show a 
significant reduction in pain on the visual analog scale at 
both 6 weeks and 3 months in comparison to the autologous 
blood group.31 However, this change was not significant at 
6 months.
Table 3 provides a summary of within-group change 
from baseline to follow-up. There was a consistent find-
ing of decreased pain across all studies, irrespective of the 
intervention. A clear trend was noticed across 4 of the studies 
with a reduction in pain.6,9,23,31 This result was statistically 
significant within 3 of these 4 studies, Dimou et al being the 
notable exception with nonsignificant results.20 Function 
was reported in only 2 of the reviewed studies, which both 
contained a customized functional foot orthoses treatment 
arm.6,9 Both studies reported a statistical improvement of 
function at each of the points of assessment. It was of note 
that none of the studies which investigated corticosteroid 
injections used function as an outcome measure.23,31
Little information was provided about the safety of CFO’s 
and corticosteroid injections in the included studies. Of the 
4 studies6,9,20,32 which investigated CFO, only one commented 
on the side effects of their use.6 Roos et al6 reported pressure-
related foot pain and tiredness of the foot in 3 of their subjects. 
Noncompliance with customized functional foot orthoses, 
a common clinical observation, was not reported in any of 
the studies. Both studies23,31 which investigated corticoster-
oid injections reported side effects as a result of their use. 
Porter and Shadbolt23 reported that all of the patients found 
the corticosteroid injection painful. Of the 64 heels injected, 
8 cases required analgesia and/or ice application for post-
injection pain. Similarly, in the study by Lee and Ahmad all 
of the patients found the corticosteroid injection painful.31 
Of their cohort, 12.9% also experienced post-injection pain 
which required analgesia and/or ice application.31 The post-
injection pain was said to have continued for a mean duration 
of 5 and 7 days respectively.23,31
The methodological rigor of the included articles was 
assessed using the PEDro instrument.29 A breakdown of 
the individual domain scores is provided in Appendix 1 
(the higher the score out of 10, the less methodological bias 
within the study). Blinding of the subjects, the therapist, 
and/or the assessor were the domains on which most of the 
studies were flawed. In terms of blinding, only Baldassin 
et al32 and Landorf et al9 adequately fulfilled these criteria. 
Small sample sizes were also a characteristic of many of the 
included studies, with only three studies6,9,32 reporting power 
analyses to determine sample sizes.
Discussion
A systematic review, by its very nature, aims to evaluate 
best available research evidence, within a particular field of 
practice, with particular emphasis on rigor, precision, and 
generalizability. Within fields of practice where evidence is 
sparse, mixed and/or inconclusive, a systematic review of the 
current best available evidence provides useful information 
on current implications for practice and future research. The 
decision on whether to use CFO or CSI for the treatment 
of plantar fasciitis is one such area where the current best 
available evidence needs to be established.
Table 2 Outcome measures – psychometric properties
Article Outcome measures Validity and reliability
Baldassin et al32 VAS (modified pain scale from the FFI) 
VAS (palpation at medical calcaneal tuberosity)
validity and/or reliability reported 
validity and/or reliability not reported
Lee and Ahmad31 vAS  
Tenderness Threshold
validity and/or reliability reported [29] 
validity and/or reliability reported [30]
Roos et al6 Foot and ankle outcome score validity and/or reliability reported [6]
Landorf et al9 The Foot Health Status Questionnaire validity and/or reliability reported [31]
Porter and Shadbolt23 vAS  
Tenderness Threshold
validity and/or reliability reported [29] 
validity and/or reliability reported [30]
Dimou et al20 Numeric pain rating scale 101 (NRS-101) 
First step pain scale 
“effect of heel pain on 3 different activities form”
validity and/or reliability documented 
validity and/or reliability not reported 
validity and/or reliability not reported
Abbreviations: FFi, Foot Function index; vAS, visual analog scale.Journal of Multidisciplinary Healthcare 2011:4 submit your manuscript | www.dovepress.com
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The findings from this systematic review highlight several 
opportunities for reflection. Surprisingly, despite extensive 
literature interrogation, we were unable to find any high level 
evidence which compared effectiveness of CFOs with CSIs, 
despite these 2 treatments being widely promoted, recom-
mended, and practiced in clinical practice.
The limited evidence base we did identify did pose unique 
challenges. The between-group results for the articles which 
contained a CFO treatment arm were mixed.6,9,20 The only 
statistically significant finding was that from the study by 
Landorf et al, where the CFO group and the prefabricated 
foot orthoses group were both superior to the sham group in 
respect to functional outcome in the short term (3 months).9 
Similarly, the 2 articles which contained a CSI treatment 
arm23,31 demonstrated statistically significant improvements 
in pain in comparison with the other treatment arms but only 
in the short term.
The articles6,9,20,32 that investigated the effectiveness of 
customized functional foot orthoses were able to show a 
within-group reduction in pain at each and every assessment 
point. The study by Roos et al6 and Landorf et al9 contained 
the longest follow-up at 52 weeks post-intervention. This is 
in contrast to the Dimou et al20 study which evaluated only 
once at 8 weeks post-intervention. Baldassin et al32 also 
reported similar findings with positive outcomes at 4 and 
8 weeks post intervention.
All 4 studies scored well (8 points) in the PEDro 
appraisal, indicating only minor issues with methodologi-
cal quality. The main drawback was a lack of blinding of 
subjects and therapists in Baldassin et al,32 Roos et al,6 and 
Dimou et al,20 which is to be expected given the nature of 
the intervention. The research by Dimou et al20 also utilized 
outcome measures with poor psychometric properties.
A within-group reduction in pain at each and every 
assessment point was also found in the 2 articles that assessed 
the efficacy of corticosteroid injections.23,31 A statistically 
significant reduction in pain was reported at each of these 
measurement points. Both studies evaluated outcomes at 
52 weeks post-intervention, at which time a reduction in pain 
was still reported for the use of this treatment. However, both 
of these studies were constrained by similar methodological 
flaws (both with a PEDro score of 6). The threats to internal 
validity in these studies included failure to blind the subjects, 
therapist and assessor, and failure to instigate an intention-
to-treat analysis.
Function was assessed in the studies by Landorf 
et al,9 Baldassin et al,32 and Roos et al.6 All these studies 
investigated the effectiveness of CFO and demonstrated a 
statistically significant increase in function at each of the 
measurement points. Adding to the strength of these results, 
all studies utilized outcome measures that had reported 
validity and/or reliability outcomes for their use within the 
literature.6,9,32 Considering that foot pathologies can have a 
profound effect on functional ability, it is interesting to note 
that not all studies attempted to measure function.
The risk factors for the use of CSI include plantar fascial 
rupture, hypoglycemia in diabetic patients, skin and fat-pad 
atrophy, and sepsis.4,24,25 However, this was not supported 
by evidence from the included studies. Neither of the stud-
ies involving a corticosteroid injection reported any such 
occurrences.23,31 Pain was however the primary risk factor 
reported consistently within these 2 studies. Universally, 
subjects in both the Porter and Shadbolt study23 and the 
study by Lee and Ahmad31 found the CSI painful. Not only 
was there injection pain but the associated post-injection 
pain was said to have continued for a mean duration of 5 
and 7 days respectively.23,31 With regards to customized 
functional foot orthoses, only 1 study reported pain with 
the use of CFO.6
Limitations of this review
This systematic review, like any other research, has its 
limitations. The very nature of a systematic review ensures 
a very specific, targeted body of literature is identified, 
Table 3 within-group change from baseline to follow-up
Study Intervention (CFO or CSI) Comparator 1 Comparator 2
Pain Function Pain Function Pain Function
Baldassin et al32 ↓ ↑ ↓ ↑
Roos et al6 ↓ ↑ ↓ ↑ ↓ ↑
Landorf et al9 ↓ ↑ ↓ ↑ ↓ ↑
Dimou et al20,* ↓ DNR ↓ DNR
Porter and Shadbolt23 ↓ DNR ↓ DNR ↓ DNR
Lee and Ahmad31,* ↓ DNR ↓ DNR
Notes: *Studies which had only 2 groups.
Abbreviations: DNR, did not report; CFO, customized functional foot orthoses; CSi, corticosteroid injections.Journal of Multidisciplinary Healthcare 2011:4 submit your manuscript | www.dovepress.com
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accessed, evaluated, and synthesized. As the review 
only included published, English language literature, the 
potential for publication and language bias should be 
  acknowledged. While the authors made all attempts to 
identify and access all relevant studies, it is possible, due 
to differing terminologies, access to databases and journals, 
some may have been missed. There is also a paucity of 
evidence on cost-effectiveness and long term effectiveness 
of CFO and CSI for plantar fasciitis. Finally, this review 
is based on a modest body of evidence (6 RCTs) which 
were underpinned by several methodological flaws (such 
as small sample sizes). While the quantity and quality of 
primary research is beyond the reviewers’ control, these 
limitations must be acknowledged when considering the 
findings from this review.
Conclusion
Currently there is limited research evidence which compares 
the effectiveness of CFO with CSI in the treatment of plantar 
fasciitis. This is an important evidence gap that needs to be 
addressed as plantar fasciitis is a commonly seen condition 
in clinical practice and clinicians are regularly confronted 
with needing to make informed decisions about CFO or CSI. 
Current best available evidence, with its inherent limitations, 
highlights that both CFO and CSI can lead to a decrease in 
pain associated with plantar fasciitis.   Additionally, CFO 
may also provide an added benefit in terms of increased 
functional ability in patients with plantar fasciitis. In terms 
of harm and side effects, CSI may result in pain (from the 
injection). Clinicians using CFO and CSI should be aware 
of the limited evidence base and therefore routine use 
of CFO and CSI for plantar fasciitis should be carefully 
monitored and inform patient outcomes. This systematic 
review highlights current evidence gaps for two popular 
and increasingly accessible treatments for plantar fasciitis 
and emphasizes the importance of conducting ongoing high 
quality research in this area.
implications for clinicians
As CFO and CSI seem to provide similar benefits for 
patients with plantar fasciitis, both these treatments could 
be considered as treatment options for plantar fasciitis. 
  However, it is worthwhile to note that one of the side effects 
of CSI was pain as a result of the treatment procedure. While 
this may suggest an approach which favors CFO, which had 
minimal side effects reported in the literature, the cost of 
CFO may need to be considered. This scenario underscores 
the importance of collaborative decision   making between 
the clinician and the patient, informed by best available 
evidence.
implications for future research
Further research, such as RCTs, with sound methodological 
rigour, are required to investigate the effectiveness of CFO 
and CSI by directly comparing these 2 interventions. Future 
RCTs could also investigate the influence of the natural health 
course of plantar fasciitis by employing sham or a placebo 
group. As RCTs are time and resource intensive, it is likely 
that, in the short term at least, there will be an ongoing pau-
city of high quality literature. To address these gaps in the 
short term, well designed case studies can contribute to the 
evidence base for CFO and CSI. Future research should also 
focus on the cost effectiveness and long term effectiveness 
(including safety and side effects) of these two common 
treatment strategies.
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Plantar fasciitis – jab or support?
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